Company Filing History:
Years Active: 1992-1995
Title: The Innovative Contributions of Roy S. Whaley
Introduction
Roy S. Whaley is a notable inventor based in St. Louis, MO, who has made significant contributions to the field of pharmaceuticals. With a total of four patents to his name, Whaley's work focuses on developing advanced drug formulations that enhance therapeutic efficacy and patient compliance.
Latest Patents
Among his latest patents, Whaley has developed an extended release pharmaceutical formulation designed to achieve a zero-order release of drugs over a 12 to 24-hour period. This formulation consists of a mixture of immediate release particles containing a drug, an inert substrate, and a binder, all coated with talc. Additionally, it includes extended release particles that are coated with a dissolution modifying system containing plasticizers and a film-forming agent. Another significant patent involves a controlled-release organic nitrate formulation intended for once-per-day oral administration. This formulation utilizes spheres with a core that includes an organic nitrate, surrounded by a membrane made of a pharmaceutically acceptable, film-forming polymer. This innovative design allows for the release of the organic nitrate at a therapeutically effective level while preventing tolerance.
Career Highlights
Whaley's career is marked by his dedication to pharmaceutical innovation. He has worked extensively on formulations that not only improve drug delivery but also enhance patient outcomes. His expertise in this area has positioned him as a valuable asset in the pharmaceutical industry.
Collaborations
Throughout his career, Whaley has collaborated with esteemed colleagues such as George N. Paradissis and James A. Garegnani. These partnerships have fostered a collaborative environment that encourages the exchange of ideas and advancements in pharmaceutical technology.
Conclusion
Roy S. Whaley's contributions to pharmaceutical formulations demonstrate his commitment to innovation and improving patient care. His patents reflect a deep understanding of drug delivery systems and their impact on therapeutic effectiveness.